ES2060056T3 - Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica. - Google Patents
Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica.Info
- Publication number
- ES2060056T3 ES2060056T3 ES90310125T ES90310125T ES2060056T3 ES 2060056 T3 ES2060056 T3 ES 2060056T3 ES 90310125 T ES90310125 T ES 90310125T ES 90310125 T ES90310125 T ES 90310125T ES 2060056 T3 ES2060056 T3 ES 2060056T3
- Authority
- ES
- Spain
- Prior art keywords
- optionally substituted
- alkyl
- substituted phenyl
- hydrogen
- isoxazolonas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UNOS COMPONENTES DE LA FORMULA (I): EN LA QUE R1 ES HIDROGENO, HALOGENO, ALQUILO, ALQUENILO, ALQUINILO, FENILO Y BENCILO (SUSTITUIDOS OPCIONALMENTE); R (AL CUADRADO) ES HIDROGENO, ALQUILO, FENILO (OPCIONALMENTE SUSTITUIDO) O UN HETEROCICLO DE 5 A 7 ATOMOS EN ANILLO; O R1 Y R (AL CUADRADO) JUNTO CON LOS CARBONOS QUE LLEVAN FIJOS, FORMAN UN ANILLO DE HIDROCARBURO OPCIONALMENTE SUSTITUIDO, UNIDO A LA ISOXAZOLA; -NR3R4 REPRESENTA UN GRUPO AMINO ALICICLICO; Y A ES UN FENILO O BENCILO OPCIONALMENTE SUSTITUIDO, UN ALQUILO, ALCOXI, BENZILOXI O FENOXI OPCIONALMENTE SUSTITUIDO; Y SUS SALES DE ADICION ACIDA QUE TIENEN UNA ACTIVIDAD VALORABLE PARA EL TRATAMIENTO DE ENFERMEDADES CEREBROVASCULARES Y PARA EL USO DE RELAJANTES DE ACTIVIDAD MUSCULAR CENTRAL.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24970089 | 1989-09-26 | ||
| JP9697690 | 1990-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2060056T3 true ES2060056T3 (es) | 1994-11-16 |
Family
ID=26438116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90310125T Expired - Lifetime ES2060056T3 (es) | 1989-09-26 | 1990-09-17 | Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0420464B1 (es) |
| KR (1) | KR910006251A (es) |
| AT (1) | ATE108444T1 (es) |
| CA (1) | CA2026177A1 (es) |
| DE (1) | DE69010606T2 (es) |
| DK (1) | DK0420464T3 (es) |
| ES (1) | ES2060056T3 (es) |
| IE (1) | IE69020B1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA879631B (en) * | 1986-12-26 | 1989-08-30 | Sankyo Co | Centrally-acting muscle relaxants |
-
1990
- 1990-09-17 DE DE69010606T patent/DE69010606T2/de not_active Expired - Fee Related
- 1990-09-17 EP EP90310125A patent/EP0420464B1/en not_active Expired - Lifetime
- 1990-09-17 ES ES90310125T patent/ES2060056T3/es not_active Expired - Lifetime
- 1990-09-17 DK DK90310125.1T patent/DK0420464T3/da active
- 1990-09-17 AT AT90310125T patent/ATE108444T1/de not_active IP Right Cessation
- 1990-09-25 CA CA002026177A patent/CA2026177A1/en not_active Abandoned
- 1990-09-25 IE IE344590A patent/IE69020B1/en not_active IP Right Cessation
- 1990-09-26 KR KR1019900015314A patent/KR910006251A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69010606D1 (de) | 1994-08-18 |
| KR910006251A (ko) | 1991-04-29 |
| IE903445A1 (en) | 1991-04-10 |
| EP0420464B1 (en) | 1994-07-13 |
| DK0420464T3 (da) | 1994-11-07 |
| ATE108444T1 (de) | 1994-07-15 |
| IE69020B1 (en) | 1996-07-24 |
| EP0420464A2 (en) | 1991-04-03 |
| CA2026177A1 (en) | 1991-03-27 |
| DE69010606T2 (de) | 1995-03-23 |
| EP0420464A3 (en) | 1991-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2018832B3 (es) | Derivados de amida. | |
| ATE103812T1 (de) | Zusammensetzung zur behandlung von ischaemischen stoerungen in organen. | |
| DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
| NO903438D0 (no) | Fremgangsmaate for fremstilling av tiazolderivater. | |
| DK517588D0 (da) | L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse | |
| FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
| DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
| ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| ES2110977T3 (es) | Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa. | |
| HUT65268A (en) | Process for preparation of optically active 2-amino-1,2,3,4-tetrahydro-naphtaline derivatives | |
| FI881104A0 (fi) | Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi | |
| HUT35254A (en) | Process for preparing new cyclobutyl-alkyl-amine compounds with pharmaceutical activity and salts thereof | |
| ES2109216T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central. | |
| ES2088903T3 (es) | Nuevos inhibidores de la s-adenosilmetionina descarboxilasa. | |
| PT87005A (pt) | Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents | |
| DK0420464T3 (da) | 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser | |
| KR910700236A (ko) | 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도 | |
| ES481207A1 (es) | Un procedimiento para l preparacion de derivados de benzoci-cloheptapiridinas. | |
| DE3772850D1 (de) | Thiadiazinon-derivate. | |
| DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| KR890002098A (ko) | 2-아미노-3-포르밀-푸란, 이의 제조방법 및 이를 함유하는 약제학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 420464 Country of ref document: ES |